Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
“We’re thrilled that Taryn will be leading our marketing efforts as we
approach the anticipated launch of our first-in-class, long-lasting
neuromodulator, DaxibotulinumtoxinA for Injection (DAXI),” said
Ms. Conway is a leader in the global specialty pharmaceutical arena,
with more than 20 years of marketing and commercial experience. She
joins Revance from
“I’m excited to join Revance to help launch what could be the first truly new neuromodulator to deliver long duration -- the most significant unmet need in the field," said Ms. Conway. “In collaboration with Dustin and senior management, our marketing team intends to set a new standard with a dynamic premium brand that delivers a fundamentally differentiated experience for both providers and patients.”
About
"Revance Therapeutics" and the Revance logo are registered trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20190409005158/en/
Source:
INVESTORS
Revance Therapeutics, Inc.:
Jeanie Herbert,
714-325-3584
jherbert@revance.com
or
Burns
McClellan, Inc.:
John Grimaldi, 212-213-0006
jgrimaldi@burnsmc.com
MEDIA
Nadine
Tosk, 504-453-8344
nadinepr@gmail.com